Most-Downgraded Stocks NYSE:MDT Medtronic - MDT Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Medtronic plc Please log in to your account or sign up in order to add this asset to your watchlist. $87.10 -0.48 (-0.55%) (As of 02/3/2023 12:00 AM ET) Add Compare Share Share Today's Range$86.50▼$87.5450-Day Range$76.13▼$87.5852-Week Range$75.76▼$114.31Volume4.95 million shsAverage Volume6.59 million shsMarket Capitalization$115.86 billionP/E Ratio27.05Dividend Yield3.12%Price Target$94.25 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Medtronic MarketRank™ ForecastAnalyst RatingHold2.20 Rating ScoreUpside/Downside8.2% Upside$94.25 Price TargetShort InterestHealthy0.89% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainability-0.84Upright™ Environmental ScoreNews Sentiment0.27Based on 9 Articles This WeekInsider TradingSelling Shares$1.34 M Sold Last QuarterProj. Earnings Growth3.42%From $5.26 to $5.44 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.66 out of 5 starsMedical Sector70th out of 1,028 stocksElectromedical Equipment Industry1st out of 24 stocks 2.1 Analyst's Opinion Consensus RatingMedtronic has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 5 buy ratings, 14 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $94.25, Medtronic has a forecasted upside of 8.2% from its current price of $87.10.Amount of Analyst CoverageMedtronic has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.89% of the float of Medtronic has been sold short.Short Interest Ratio / Days to CoverMedtronic has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Medtronic has recently increased by 0.68%, indicating that investor sentiment is decreasing. Previous Next 3.3 Dividend Strength Dividend YieldMedtronic pays a meaningful dividend of 3.11%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthMedtronic has been increasing its dividend for 46 years.Dividend CoverageThe dividend payout ratio of Medtronic is 84.47%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on earnings estimates, Medtronic will have a dividend payout ratio of 50.00% next year. This indicates that Medtronic will be able to sustain or increase its dividend. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreMedtronic has received a 71.02% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Neurostimulators", "Cardiac resynchronization therapy (CRT) devices", "Radiation therapy machines", "Wound closure devices", "Bronchoscopes", and "Mechanical circulatory support devices" products. See details.Environmental SustainabilityThe Environmental Impact score for Medtronic is -0.84. Previous Next 2.4 News and Social Media Coverage News SentimentMedtronic has a news sentiment score of 0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Medtronic this week, compared to 9 articles on an average week.Search Interest73 people have searched for MDT on MarketBeat in the last 30 days. This is an increase of 9% compared to the previous 30 days.MarketBeat Follows51 people have added Medtronic to their MarketBeat watchlist in the last 30 days. This is an increase of 21% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Medtronic insiders have sold 2,010.70% more of their company's stock than they have bought. Specifically, they have bought $63,429.00 in company stock and sold $1,338,796.00 in company stock.Percentage Held by InsidersOnly 0.29% of the stock of Medtronic is held by insiders.Percentage Held by Institutions80.37% of the stock of Medtronic is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Medtronic are expected to grow by 3.42% in the coming year, from $5.26 to $5.44 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medtronic is 27.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 141.69.Price to Earnings Ratio vs. SectorThe P/E ratio of Medtronic is 27.05, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 138.85.Price to Earnings Growth RatioMedtronic has a PEG Ratio of 2.15. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioMedtronic has a P/B Ratio of 2.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Medtronic (NYSE:MDT) StockMedtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.Read More Receive MDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter. Email Address MDT Stock News HeadlinesJanuary 9, 2023 | marketbeat.comIs Medtronic Stock Ready to Revive? The world’s largest medical device maker Medtronic PLC (NYSE: MDT) stock has fallen since April 2022. However, shares may have bottomed out.February 4, 2023 | finance.yahoo.com2 Beaten-Down Stocks With Stable Dividends to Buy In 2023February 5, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.February 3, 2023 | finance.yahoo.comMedtronic (MDT) Stock Moves -0.55%: What You Should KnowFebruary 3, 2023 | finance.yahoo.com3 Ways To Shape Equitable OutcomesFebruary 3, 2023 | americanbankingnews.comMedtronic plc (NYSE:MDT) Receives Average Rating of "Hold" from AnalystsFebruary 2, 2023 | americanbankingnews.comMedtronic plc (NYSE:MDT) Major Shareholder Acquires $63,428.80 in StockFebruary 2, 2023 | americanbankingnews.comComparing Medtronic (NYSE:MDT) and Tivic Health Systems (NASDAQ:TIVC)February 5, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.February 1, 2023 | finance.yahoo.comMedtronic Continues To Make Significant Advances as an Inclusion, Diversity & Equity LeaderJanuary 26, 2023 | finance.yahoo.comStudents Use Robotics Skills To Increase Inclusion, Diversity, and EquityJanuary 23, 2023 | finance.yahoo.comSurmodics (SRDX) Stock Skids 32% on Negative Regulatory UpdateJanuary 19, 2023 | finance.yahoo.comMedtronic Signs Zero Health Gaps Pledge To Advance Health EquityJanuary 17, 2023 | finance.yahoo.comWhy Supplier Diversity MattersJanuary 13, 2023 | finance.yahoo.comClorox, Kellogg Make Morningstar List of Undervalued StocksJanuary 11, 2023 | finance.yahoo.com3 Stocks to Buy Before the Bull MarketJanuary 10, 2023 | finance.yahoo.comMedtronic Named One of America’s Most Just Companies by Just Capital and CNBCJanuary 10, 2023 | finance.yahoo.comList of AI Healthcare StocksJanuary 9, 2023 | benzinga.comThis Analyst Says Medtronic Has Better Opportunity Elsewhere In MedTechJanuary 9, 2023 | finance.yahoo.comBetter Buy: InMode or Medtronic?January 7, 2023 | finance.yahoo.comPositive week for Medtronic plc (NYSE:MDT) institutional investors who lost 21% over the past yearJanuary 6, 2023 | seekingalpha.comMedtronic: Destruction Is Nearly OverJanuary 6, 2023 | forbes.comThis Robotic Products Company Is A Better Pick Over Medtronic StockJanuary 5, 2023 | finance.yahoo.comMedtronic: Can This Medical Device Maker Turn Itself Around?January 2, 2023 | finance.yahoo.comMedtronic plc's (NYSE:MDT) Earnings Haven't Escaped The Attention Of InvestorsDecember 29, 2022 | finance.yahoo.comEstimating The Intrinsic Value Of Medtronic plc (NYSE:MDT)December 25, 2022 | finance.yahoo.comInvestors in Medtronic (NYSE:MDT) have unfortunately lost 26% over the last three yearsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive MDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter. Email Address MDT Company Calendar Last Earnings11/22/2022Ex-Dividend for 1/13 Dividend12/20/2022Dividend Payable1/13/2023Today2/04/2023Next Earnings (Confirmed)2/21/2023Fiscal Year End4/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Electromedical equipment Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:MDT CUSIP58505510 CIK1613103 Webwww.medtronic.com Phone(531) 438-1700Fax763-514-4879Employees95,000Year Founded1949Price Target and Rating Average Stock Price Forecast$94.25 High Stock Price Forecast$135.00 Low Stock Price Forecast$77.00 Forecasted Upside/Downside+8.2%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage20 Analysts Profitability EPS (Most Recent Fiscal Year)$3.22 Trailing P/E Ratio27.05 Forward P/E Ratio16.56 P/E Growth2.14Net Income$5.04 billion Net Margins14.03% Pretax Margin18.27% Return on Equity13.52% Return on Assets7.77% Debt Debt-to-Equity Ratio0.40 Current Ratio1.76 Quick Ratio1.41 Sales & Book Value Annual Sales$31.69 billion Price / Sales3.66 Cash Flow$7.61 per share Price / Cash Flow11.44 Book Value$39.30 per share Price / Book2.22Miscellaneous Outstanding Shares1,330,180,000Free Float1,326,322,000Market Cap$115.86 billion OptionableOptionable Beta0.72 Social Links Key ExecutivesGeoffrey Straub MarthaChairman & Chief Executive OfficerMegan Fulton RiddleVice PresidentGregory L. SmithExecutive VP-Global Operations & Supply ChainKaren L. ParkhillChief Financial Officer & Executive Vice PresidentLaura MauriCSO, Chief Medical & Regulatory Officer, Senior VPKey CompetitorsElevance HealthNYSE:ELVStrykerNYSE:SYKGilead SciencesNASDAQ:GILDSanofiNASDAQ:SNYAmgenNASDAQ:AMGNView All CompetitorsInsiders & InstitutionsLarson Financial Group LLCSold 312 shares on 2/3/2023Ownership: 0.002%Capital Investment Advisory Services LLCBought 232 shares on 2/3/2023Ownership: 0.001%Lipe & DaltonSold 399 shares on 2/3/2023Ownership: 0.001%Mitchell Mcleod Pugh & Williams Inc.Bought 174 shares on 2/3/2023Ownership: 0.000%9258 Wealth Management LLCSold 256 shares on 2/3/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions MDT Stock - Frequently Asked Questions Should I buy or sell Medtronic stock right now? 20 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 1 sell rating, 14 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MDT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDT, but not buy additional shares or sell existing shares. View MDT analyst ratings or view top-rated stocks. What is Medtronic's stock price forecast for 2023? 20 Wall Street analysts have issued 12-month target prices for Medtronic's stock. Their MDT share price forecasts range from $77.00 to $135.00. On average, they anticipate the company's share price to reach $94.25 in the next year. This suggests a possible upside of 8.2% from the stock's current price. View analysts price targets for MDT or view top-rated stocks among Wall Street analysts. How have MDT shares performed in 2023? Medtronic's stock was trading at $77.72 at the beginning of 2023. Since then, MDT shares have increased by 12.1% and is now trading at $87.10. View the best growth stocks for 2023 here. When is Medtronic's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023. View our MDT earnings forecast. How can I listen to Medtronic's earnings call? Medtronic will be holding an earnings conference call on Tuesday, February 21st at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link. How were Medtronic's earnings last quarter? Medtronic plc (NYSE:MDT) announced its earnings results on Tuesday, November, 22nd. The medical technology company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02. The medical technology company had revenue of $7.59 billion for the quarter, compared to the consensus estimate of $7.70 billion. Medtronic had a trailing twelve-month return on equity of 13.52% and a net margin of 14.03%. Medtronic's revenue for the quarter was down 3.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.32 earnings per share. Read the conference call transcript. How often does Medtronic pay dividends? What is the dividend yield for Medtronic? Medtronic announced a quarterly dividend on Thursday, December 8th. Shareholders of record on Wednesday, December 21st will be given a dividend of $0.68 per share on Friday, January 13th. This represents a $2.72 annualized dividend and a yield of 3.12%. The ex-dividend date is Tuesday, December 20th. Read our dividend analysis for MDT. Is Medtronic a good dividend stock? Medtronic (NYSE:MDT) pays an annual dividend of $2.72 per share and currently has a dividend yield of 3.11%. The company has been increasing its dividend for 46 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 84.47%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, MDT will have a dividend payout ratio of 50.00% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for MDT. What guidance has Medtronic issued on next quarter's earnings? Medtronic issued an update on its FY 2023 earnings guidance on Thursday, December, 22nd. The company provided earnings per share guidance of $5.25-$5.30 for the period, compared to the consensus earnings per share estimate of $5.53. The company issued revenue guidance of -. What is Omar S. Ishrak's approval rating as Medtronic's CEO? 1,925 employees have rated Medtronic Chief Executive Officer Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among the company's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Medtronic own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), Home Depot (HD) and Walmart (WMT). What is Medtronic's stock symbol? Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT." Who are Medtronic's major shareholders? Medtronic's stock is owned by a variety of institutional and retail investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.28%), Fisher Asset Management LLC (0.25%), New York State Common Retirement Fund (0.22%), Bank of Montreal Can (0.20%), Fort Washington Investment Advisors Inc. OH (0.18%) and ProShare Advisors LLC (0.16%). Insiders that own company stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Omar Ishrak, Plc Medtronic, Richard H Anderson, Richard H Anderson, Robert John White and Sean Salmon. View institutional ownership trends. How do I buy shares of Medtronic? Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Medtronic's stock price today? One share of MDT stock can currently be purchased for approximately $87.10. How much money does Medtronic make? Medtronic (NYSE:MDT) has a market capitalization of $115.86 billion and generates $31.69 billion in revenue each year. The medical technology company earns $5.04 billion in net income (profit) each year or $3.22 on an earnings per share basis. How many employees does Medtronic have? The company employs 95,000 workers across the globe. How can I contact Medtronic? Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The official website for the company is www.medtronic.com. The medical technology company can be reached via phone at (531) 438-1700, via email at investor.relations@medtronic.com, or via fax at 763-514-4879. This page (NYSE:MDT) was last updated on 2/5/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.